Jane Austrian Bio Valley 5'-nucleotide workshop main cap

November 23, in Dalian Golden State victory, said Austrian BioValley project site, Dalian, said Austrian Biotechnology Co., Ltd. 5'-nucleotide workshop main cap ceremony. Pan Xiao non Zhen-Ao Group President, Kim, vice president, vice president and general manager of the biotechnology company CHEN Yu-ping, vice president Chen Xianglin, after instrument loyal vice president, and in even the leadership of the Group, the construction units on behalf of, the biological part of the company employees attended the topping out ceremony . The ceremony was presided by the deputy general manager of biotechnology company Zhao Kun.

CHEN Yu-ping, vice president delivered a speech at the ceremony. He said: "5'-nucleotide workshop main cap means, said Austrian will continue to practice in this land 'based on the life sciences for the benefit of human health' corporate purposes, here and realize their own small family Jane Austrian family struggle over Jane Austria yesterday, today laudable, we must redouble pay for the creation of Jane Austrian people praise tomorrow and work! "

10:38, said Austrian Bio Valley salute Qiming, said Austrian group leaders attended the ceremony collective shovel for the 5'-nucleotide workshop cap, said Austrian valley in advancing biological process, but also a forward stride.

News Links: Dalian, said Austrian Biotechnology Co., Ltd. The new plant covers an area of 16,000 square meters, construction area of 35,000 square meters, the workshop by the 5'-nucleotide, high nucleotide yeast extract (YE) Drag and ribonucleic acid (RNA) workshop three single buildings. The capped 5'-nucleotide workshop covers an area of 4860 square meters, construction area of 8880 square meters, in accordance with GMP standard design, using the most advanced production technology, production equipment and fully automated production processes and control first-class testing equipment, annual output of high standard 5'-nucleotide 300 tons. With the overall progress, said Austrian BioValley project, expected in July next year biotechnology company three modern production plant will be fully put into operation.